ANEB: Anebulo Pharmaceuticals Inc Price to Sales

Corporate company logo of Anebulo (ANEB)

Anebulo Pharmaceuticals (ANEB) develops cannabinoid antidotes through partnerships with medical centers. The high margins of proprietary products within this niche are confirmed by the price/sales ratio, which remains around . Outsourcing primary testing to external laboratories while maintaining full control over intellectual property minimizes operational risks, ensuring steady growth in business value.

Anebulo Pharmaceuticals - ANEB Market Cap to Revenue (period 07/04/2022 - 11/16/2026)

Metric breakdowns and analytics for Anebulo Pharmaceuticals Inc (ANEB)

- market capitalization information:
Summary company analytics:Anebulo Pharmaceuticals Inc, ANEB
Product sample of Anebulo Pharmaceuticals, Inc.

The P/S ratio serves as a key filter when assessing fair value and stress-testing overpayment risks. This metric compares market capitalization to annual revenue, reflecting investor expectations regarding future cash flows. By analyzing historical P/S levels, one can evaluate the extent of an asset's overvaluation. For Anebulo Pharmaceuticals (ANEB), this indicator demonstrates the market's bet on the successful integration of a unique antidote into the emergency medicine system.